[{"Assets_0_Q3_USD":2936000000.0,"CommonStockSharesOutstanding_0_Q3_shares":43206700.0,"EarningsPerShareBasic_3_Q3_USD":9.0,"EarningsPerShareBasic_1_Q3_USD":6.37,"EarningsPerShareDiluted_3_Q3_USD":8.83,"EarningsPerShareDiluted_1_Q3_USD":6.27,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":560000000.0,"StockholdersEquity_0_Q3_USD":2069900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":45200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":44100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":44300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":43400000.0,"Ticker":"UTHR","CIK":"1082554","name":"UNITED THERAPEUTICS CORP","OfficialName":"United Therapeutics Corporation Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8315138472.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171025"}]